Alexza Pharmaceuticals Inc (NASDAQ:ALXA)
CAPS Rating:
An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.
RSS Headlines
Fool UK
Recs
numerous smart fools...
This is a good one to hold as a reminder. The game is not over yet, but no one is always right. Statistics show that 80% of the markets gains are from 20% of the stocks. WE have to miss on a few when the odds are stacked against us!!!
Thanks, TSIF. Sorry for the slow reply, been "off-grid"...